Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation--a similar experience

Biol Blood Marrow Transplant. 2007 Jun;13(6):746-7. doi: 10.1016/j.bbmt.2007.02.006.
No abstract available

Publication types

  • Kommentar
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Busulfan / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Drug Evaluation
  • Etoposide / administration & dosage
  • Female
  • Hematopoietic Stem Cell Transplantation / methods*
  • Hodgkin Disease / therapy*
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Etoposide
  • Cyclophosphamide
  • Busulfan